<DOC>
	<DOCNO>NCT00434941</DOCNO>
	<brief_summary>This prospective , open-label , multicenter phase IV.II study . Patients local relapse breast cancer receive radiotherapy concomitant administration capecitabine . Total dose radiotherapy 50 Gy administer daily session 200 cGy . Radiotherapic treatment longer 6 week . All patient receive 1650 mg/m2 mouth , per day ( 825 mg/m2 twice day ( p.o . bid ) 35 day . Tissue sample must analyse determinate human epidermal growth factor receptor-2 ( HER2 ) FISH technical .</brief_summary>
	<brief_title>Administration Capecitabine Simultaneous Radiotherapy Local Relapse Breast Cancer Patients With Negative Her2 Tumours</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Written inform consent . Histological diagnosis operable invasive adenocarcinoma breast . Patients tumour HER2 negative . Previous mastectomy surgery . Actual diagnose local recurrence breast cancer . Patients must present evidence metastatic disease . Age &gt; = 18 year old . Performance status ( Karnofsky index ) &gt; = 70 . Laboratory result ( within 14 day prior randomization ) : Hematology : neutrophil &gt; = 1.5 x 10e9/l ; platelet &gt; = 100x 10e9/l ; hemoglobin &gt; = 10 mg/dl Hepatic function : total bilirubin &lt; = 1,5 UNL ; SGOT SGPT &lt; = 1.5 UNL ; alkaline phosphatase &lt; = 1.5 UNL . Renal Function : creatinine &lt; = 175 Âµmol/l ( 2 mg/dl ) creatinine clearance &gt; = 60 ml/min . Distant metastasis metastatic disease organ . Metastasis internal mammary chain lymph nod Previous radiation treatment breast location ( 30 % great bone marrow ) . Prior treatment continuous ( great 24h ) 5FU infusion , capecitabine oral fluoropyrimidines eniluracil/5FU , uracil/tegafur , S1 emitefur . Known hypersensitivity capecitabine , doxifluridine component . Organ allografts requiere inmmunosupressor therapy . History neurological psychiatric disorder , could preclude patient free informed consent . Clinically significant cardiac disease congestive heart failure , symptomatic coronary artery disease cardiac arrhythmia well controlled medication history myocardial infarction within last 12 month uncontrolled hipertension . Evidence CNS metastasis . Pts history uncontrolled seizure , CNS disorder psychiatric disability judge investigator clinically significant precluding inform consent interfere compliance exclude study . Pregnant lactate woman . Adequate contraceptive method must use chemotherapy hormone therapy treatment . Negative pregnancy test 14 previous day randomization . Active uncontrolled infection severe patohologies active peptic ulcer , unstable diabetes mellitus . Major surgery 4 week prior treatment . Patients lack physical integrity upper gastrointestinal tract history bad absorption syndrome . Anticoagulant treatment coumadin anticoagulant . Concomitant treatment investigational product . Participation clinical trial nonmarketed drug 30 previous day randomization . Concomitant treatment therapy cancer .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Administration capecitabine concomitant radiotherapy</keyword>
	<keyword>Her2 : negative</keyword>
</DOC>